Brief: Minerva Neurosciences Announces Listing Transfer To Nasdaq Capital Market
09/09/2022 21:08
Sept 9 (Reuters) - Minerva Neurosciences Inc NERV.O :
* MINERVA NEUROSCIENCES ANNOUNCES LISTING TRANSFER TO NASDAQ
CAPITAL MARKET
* MINERVA NEUROSCIENCES INC - COMMON STOCK WILL BEGIN
TRADING ON
NASDAQ CAPITAL MARKET EFFECTIVE AT START OF TRADING ON SEPTEMBER
12, 2022
Source text for Eikon: ID:nGNX5rrBVW
Further company coverage: NERV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Minerva Neurosciences
See all newsU.S. RESEARCH ROUNDUP-Cisco, Fox Corp, Target
Brief: Minerva Neurosciences Provides Second Quarter 2026 Financial Results And Business Updates
Brief: Minerva Neurosciences - To Offer And Sell Up To $75 Million In Common Stock Through Leerink Partners
Brief: Minerva Announces Leadership Transition
Minerva Neurosciences Q4 net loss widens on non-cash financing charges